Polymeric immunoglobulin receptor (pIgR), an IgM Fc receptor is chosen to be expressed due to its various clinical potentials such as the possibility to serve as predictive biomarker target owing to its correlation with various cancer malignancies, potential role, and underlying mechanisms in body immunity [1, 2]. The gene discussed is PIGR; the disease is cancer.